AC
ELV icon

Addison Capital’s Elevance Health ELV Stock Holding History

Addison Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-628
Closed -$203K – 147
2025
Q3 		$203K Hold
628
– – 0.06% 143
2025
Q2 		$244K Hold
628
– – 0.08% 132
2025
Q1 		$273K Hold
628
– – 0.11% 117
2024
Q4 		$232K Hold
628
– – 0.09% 124
2024
Q3 		$326K Hold
628
– – 0.13% 114
2024
Q2 		$340K Hold
628
– – 0.15% 105
2024
Q1 		$325K Hold
628
– – 0.16% 99
2023
Q4 		$296K Buy
628
+18
+3% +$8.32K 0.18% 87
2023
Q3 		$265K Buy
610
+88
+17% +$39.9K 0.21% 80
2023
Q2 		$232K Buy
522
+62
+13% +$28.6K 0.17% 91
2023
Q1 		$212K Buy
+460
New +$219K 0.16% 101

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Addison Capital's ELV Position: Q4 2025 in Review

Addison Capital sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 628 shares — an estimated $203K sold.

Addison Capital first reported a position in ELV in Q1 2023 and held it in 11 quarters. The position peaked at $340K in Q2 2024. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Addison Capital reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Addison Capital sold 628 Elevance Health shares in Q4 2025, an estimated $203K.
  • Addison Capital first reported a position in Elevance Health in Q1 2023 and held it in 11 quarters.
  • Addison Capital's Elevance Health position peaked at $340K in Q2 2024.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Addison Capital's 13F filing for Q4 2025, filed 2 Feb 2026.